# Community Glucose Monitoring Project

Study · id `cardio:ct-nct05351190` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05351190](<https://clinicaltrials.gov/study/NCT05351190>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05351190

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05351190. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-15 (actual); primary completion 2024-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05351190, source copy `cardio:ctgov-nct05351190-2023-03-09`, retrieved 2026-10-26)
- Started: 2022-05-15 (actual) (ClinicalTrials.gov record NCT05351190, source copy `cardio:ctgov-nct05351190-2023-03-09`, retrieved 2026-10-26)
- Primary completion: 2024-08-31 (anticipated) (ClinicalTrials.gov record NCT05351190, source copy `cardio:ctgov-nct05351190-2023-03-09`, retrieved 2026-10-26)
- Completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05351190, source copy `cardio:ctgov-nct05351190-2023-03-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05351190, source copy `cardio:ctgov-nct05351190-2023-03-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05351190-2023-03-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Community Glucose Monitoring Project
- Acronym: CMGProject
- Condition: Type 2 Diabetes
- Intervention (Device): Dexcom G6 CGM
- Lead sponsor: Blanchard Valley Health System
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: e94a299a96224817822a7de55cd84b3ee51f370bc71e4ec9775ea40202c91062
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
